Crisà, Elena <br/><br/>
Can pegylated interferon improve the outcome of polycythemia vera patients?  [electronic resource] 

 -  Journal of hematology & oncology  01 2017 
 - 15 p.  digital 
<br/><br/> Publication Type: Letter; Observational Study 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-017-0395-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Disease Progression<br/>Female<br/>Humans<br/>Hydroxyurea--adverse effects<br/>Interferon-alpha--administration & dosage<br/>Janus Kinase 2--genetics<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--chemically induced<br/>Polycythemia Vera--complications<br/>Polyethylene Glycols<br/>Remission Induction<br/>Survival Rate<br/>Thrombosis--chemically induced<br/>Treatment Outcome<br/>Young Adult